Insilico Medicine develops AI software and conducts research for drug discovery and development. Its Pharma.AI platform includes tools for identifying potential biological targets, generating and optimizing molecules, and analyzing clinical-development outcomes. The company combines computational methods with biology and chemistry research, and also advances its own drug-development pipeline. Insilico’s work spans software licensing and internal research programs, with AI applied across stages from early target discovery through candidate development and clinical-trial planning.
Claim this company profile
Please sign in to claim this profile.
Company reviews
No approved reviews yet.
Please sign in to write a review. One review per account and company.